Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,449
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,872
Class I recallsReasonable probability of serious health consequences
24,509
Class II recallsTemporary or medically reversible health consequences
2,932
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,096 recalls
Most affected stateHawaii 200 recalls mention this state

Advertisement

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,956 recalls have been announced year to date.
  • Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
  • The highest complete period was Jun 2026 (300).
  • Nov 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,509
Class I9,872
Class III2,932
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,509
Class I9,872
Class III2,932
Not Yet Classified2

Showing 8,161–8,180 of 19,236 recalls

FDA Recall United States TerminatedTerminated: March 30, 2020Historical recordClass I

Meijer

Product
Fresh From Meijer diced hard boiled eggs sold by weight from…
Reason
Possible L. mono contamination in hard boiled eggs
Published
February 19, 2020
Distribution
Products were offered for sale at the sa…

View recall →

FDA Recall TerminatedTerminated: December 16, 2022Historical recordClass III

Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, 60-count bottle, Manufactured for Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India, NDA 33342-176-09

by Macleods Pharma Usa Inc

Reason
Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitazone And Metformin Hydrochloride Tablets.
Published
February 12, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 29, 2022Historical recordClass II

Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA; Manufactured By: Graviti Pharmaceuticals Pvt. Ltd., Telangana -502307, INDIA; NDC 70377-027-11.

by Graviti Pharmaceuticals Private Limited

Reason
Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.
Published
February 12, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 10, 2020Historical recordClass II

Desmopressin Acetate Tablets, 0.2 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2465-01

by Teva Pharmaceuticals USA

Reason
GMP Deviations: Product bottle may be absent of desiccant.
Published
February 12, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 10, 2020Historical recordClass II

Desmopressin Acetate Tablets, 0.1 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2464-01

by Teva Pharmaceuticals USA

Reason
GMP Deviations: Product bottle may be absent of desiccant.
Published
February 12, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 8, 2021Historical recordClass III

Clonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by: Unichem Laboratories Ltd. Pilerne Ind. Estate, Pilerne Bardez, Goa 403 511 India. Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816. NDC 29300-135-01

by UNICHEM PHARMACEUTICALS USA INC

Reason
Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label.
Published
February 12, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 29, 2021Historical recordClass II

Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-446-90.

by Ascend Laboratories LLC

Reason
cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement.
Published
February 12, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass III

Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-438-30.

by Ascend Laboratories LLC

Reason
Failed Dissolution Specifications: low out of specification results for dissolution testing.
Published
February 12, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 3, 2021Historical recordClass II

Nystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (473 mL) Rx Only, pai, Pharmaceutical Associates, Inc. Greenville, SC 29605. NDC 0121-0810-16

by Pharmaceutical Associates Inc

Reason
Subpotent: Out of specification for assay at the 12-month time point.
Published
February 5, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: April 26, 2021Historical recordClass III

Montelukast Sodium Chewable Tablets, 5 mg, 90-count bottles, Rx Only, Manufactured for : Macleods Pharma USA, Inc. Plainsboro, NJ Manufactured by: Macleods Pharmaceuticals Ltd Baddi, Himachal Pradesh, India NDC 33342-111-10

by Macleods Pharma Usa Inc

Reason
Failed Dissolution Specifications: testing revealed low out of specification result in one lot of product
Published
February 5, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 6, 2020Historical recordClass II

Walgreens Acne Cleansing Bar, Benzoyl Peroxide 10%, NET WT 4 oz (113 g), 1 bar per carton, Distributed By: Walgreen Co., 200 Wilmot Road, Deerfield, IL 60015, NDC: 0363-0137-11

by Shandex Personal Care Manufacturing Inc.

Reason
Presence of Foreign Substance; Metal contaminant visible in product (screen wire from manufacturing).
Published
February 5, 2020
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: May 1, 2020Historical recordClass I

Jeni's Splendid Ice Creams LLC

Product
Jeni's Dairy Free Cold Brew with Coconut Cream Pints frozen…
Reason
May contain undeclared milk allergen
Published
February 5, 2020
Distribution
Product distributed to the following sta…

View recall →

FDA Recall United States TerminatedTerminated: July 6, 2022Historical recordClass II

Healthy Food Ingredients, LLC

Product
Organic IntegriPure Cold Milled Flaxseed, 50 lb Net Wt. and…
Reason
Product is being recalled due to detection of an unapproved herbicide.
Published
February 5, 2020
Distribution
CA, CO, UT. EXPANDED February 2020: M…

View recall →

FDA Recall United States TerminatedTerminated: January 28, 2020Historical recordClass I

WHOLE FOODS MARKET

Product
365 Everyday Value Dark Chocolate Caramel Sea Salt Sandwich…
Reason
Potential to contain undeclared milk and coconut.
Published
February 5, 2020
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: January 28, 2020Historical recordClass I

WHOLE FOODS MARKET

Product
365 Everyday Value Dark Chocolate Peppermint Sandwich Cremes…
Reason
Potential to contain undeclared milk.
Published
February 5, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 8, 2021Historical recordClass III

methylPREDNISolone Sodium Succinate For Injection, USP, 500 mg*/vial, Rx Only, Mfd by: HIKMA FARMACEUTICA (PORTUGAL), SA; Dist by: WEST-WARD, Eatontown, NJ 07724, NDC 0143-9850-01.

by Hikma Pharmaceuticals USA Inc.

Reason
Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to reconstitute product with 16 mL rather than the correct volume of 8 mL of Bacteriostatic Water for Injection with Benzyl Alcohol.
Published
January 29, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: July 12, 2023Historical recordClass II

Entropic Labs SARM RAD-140, 20mg Capsules, 30-count bottles, Entropic Labs UPC#: 651074545302

by Tuscano and Delucia Group (DBA Entropic Labs)

Reason
Marketed Without An Approved NDA/ANDA: product contains Selective Androgen Receptor Modulators (SARMs)
Published
January 29, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: July 21, 2023Historical recordClass II

NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Intravenous Use Only, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc. by Gipharma S.r.l. Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40.

by Advanced Accelerator Applications USA, Inc.

Reason
Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2).
Published
January 29, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 5, 2023Historical recordClass II

Ranitidine Tablets, USP 300 mg a). 15-count bottles (NDC 70934-287-15), b). 90-count bottles (NDC 70934-287-90), Rx Only, Repackaged by: Northwind Pharmaceuticals North Brenheim, NY 12131

by Denton Pharma, Inc.

Reason
CGMP Deviations: Presence of NDMA impurity detected in product.
Published
January 29, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 5, 2023Historical recordClass II

Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-count bottle (NDC 70934-017-20), c). 24-count bottle (NDC 70934-017-24) d). 30-count bottle (NDC 70934-017-30) e). 90-count bottle (NDC 70934-017-90), Rx Only, Repackaged by: Northwind Pharmaceuticals North Brenheim, NY 12131.

by Denton Pharma, Inc.

Reason
CGMP Deviations: Presence of NDMA impurity detected in product.
Published
January 29, 2020
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.